Our oncologist Dr. Powers let us know of it and he will be attending
Looks like Dr Judson from the England Cedirinib trials is also attending and speaking
"11 Friday, 2016
1:30 pm – 2:25 pm – SOFT TISSUE SARCOMAS – Floriana
WSN "Sarcoma of the Year"Alveolar Soft Part Sarcoma
Moderators: J.Y. Blay, P. Schoffski
1:30 pm Paper 019 #2548431
LONG-TERM RESULTS OF THERAPY WITH SUNITINIB IN METASTATIC
ALVEOLAR SOFT PART SARCOMA (ASPS) PATIENTS
P. Rutkowski; K. Kozak; A. Klimczak; H. Kosela-Paterczyk; S. Falkowski; T. Switaj"
https://www.ctos.org/Meeting/2016AnnualMeeting.aspx
Sarcoma conference featuring ASPS as sarcoma of the year
-
- Senior Member
- Posts: 1678
- Joined: Mon Aug 14, 2006 11:32 pm
- Location: Sammamish, WA USA
Re: Sarcoma conference featuring ASPS as sarcoma of the year
Dear ASPS Community Friends,
I just read the following Facebook post by Dr. Breelyn Wilky, the wonderful organizer and coordinator of the recent September ASPS Day of Learning Workshop in Miami, that at today's CTOS 2016 Conference in Lisbon, Portugal which Debbie thoughtfully posted information about and where ASPS is being featured and discussed as Sarcoma of the Year, "Shreyas Patel MDACC just showed this for the first time... #ctos2016. First time I know that anyone has showed response in ASPS publicly to immunotherapy!!!!" This is extremely exciting for all of us in the ASPS Community including oncologists, researchers, patients, and patient's families, and is something which I will be closely following and am very anxious to hear more detailed information about!!
With special caring thoughts and continued Hope,
Bonni
I just read the following Facebook post by Dr. Breelyn Wilky, the wonderful organizer and coordinator of the recent September ASPS Day of Learning Workshop in Miami, that at today's CTOS 2016 Conference in Lisbon, Portugal which Debbie thoughtfully posted information about and where ASPS is being featured and discussed as Sarcoma of the Year, "Shreyas Patel MDACC just showed this for the first time... #ctos2016. First time I know that anyone has showed response in ASPS publicly to immunotherapy!!!!" This is extremely exciting for all of us in the ASPS Community including oncologists, researchers, patients, and patient's families, and is something which I will be closely following and am very anxious to hear more detailed information about!!
With special caring thoughts and continued Hope,
Bonni